Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin’s Lymphoma of the Duodenum: A SEER Database Analysis

Table 4

Previously reported cases of PDLs.

Reference	Num	Age	Sex	Location	Type	Stage	CD markers	Surgery	Conservation	Follow-up
Zheng et al. [4]	1	58	M	——	MCL	——	CD20, CD21, CD5, BCL-2	None	None	——
Linnik et al. [5]	1	51	M	——	DLBCL	——	CD20, CD45, BCL2, BCL6	None	Chemotherapy	60 mo/L
Iwamuro et al. [6]	2	52	M	Descendant duodenum	FL	IV	CD20, CD10, BCL2	——	——	——
		96	F	Descendant duodenum	FL	IV	CD20, CD10, BCL2	——	——	——
Mejia et al. [7]	1	56	M	Papilla	FL	——	CD-20, CD10, BCL-2, BCL-6	None	R	——
Iwamuro et al. [8]	1	60	M	Descendant duodenum	FL	IV	CD20, CD10, BCL2	None	Bendamustine and R	——
Trivedi et al. [9]	1	36	F	Ampulla of Vater	DLBCL	——	CD20	YES	Chemotherapy	2 y/L
Tari et al. [10]	1	66	F	Ampulla of Vater	FL	II2	CD20, CD10, BCL-2	None	None	——
Du et al. [11]	1	65	M	Descendant duodenum	DLBCL and TCL	——	CD20, CD3, CD45	YES	R-CHOP	30 mo/R
Cho et al. [12]	1	68	M	Duodenal bulb	MALT	——	——	YES	——	——
Kondo et al. [13]	1	78	F	Ampulla of Vater	DLBCL	——	CD20, CD10, CD79a, BCL-2	YES	R-CHOP	19 mo/NR
Nakase et al. [14]	1	57	F	Papilla	FL	I	CD10, Bcl-2	None	None	1 mo/NR
Born et al. [15]	1	75	F	——	FL	——	——	None	None	——
Woo et al. [16]	1	71	F	Descendant duodenum	MALT	EII2	CD20	None	CVP	1 y/NR
Chim et al. [17]	1	73	M	Ampulla of Vater	DLBCL	II1	CD20, BCL-6	None	CHOP	Died due to COPD
Jabr [18]	1	71	F	Ampulla of Vater	DLBCL	——	CD20, CD10, CD45, BCL-2	None	Chemotherapy	——
Zenda et al. [19]	1	49	F	Papilla	FL	I	CD20, CD10, CD79a, BCL-2	None	R-CHOP	——
Yildirim et al. [20]	3	33	M	Ampulla of Vater	DLBCL	——	CD20	None	CHOP	1 y/NR
		24	M	Ampulla of Vater	DLBCL	——	CD20, CD45	None	CHOEP	Died due to sepsis and multiorgan failure
		38	M	Ampulla of Vater	DLBCL	——	CD20, LCA	None	CHOP	Died due to suspected perforation
Isomoto et al. [21]	1	46	M	Ampulla of Vater	MALT	IE	BCL-2	None	Radiation	4 y/NR
Nadal et al. [22]	1	55	M	Ampulla of Vater	FL	——	CD10, Bcl-2	None	CHOP	2 y/NR
Ventrucci et al. [23]	1	65	F	Ampulla of Vater	MALT	——	CD20, CD79a, BCL-2	None	CVP	15 mo/NR